Potential conflict of interest: Nothing to report.
Natural history and staging for hepatocellular carcinoma
Version of Record online: 23 JAN 2013
© 2012 the American Association for the Study of Liver Diseases
Clinical Liver Disease
Special Issue: Current Issues in Hepatocellular Carcinoma
Volume 1, Issue 6, pages 183–185, December 2012
How to Cite
Forner, A., Rodríguez-Lopez, C. and Reig, M. (2012), Natural history and staging for hepatocellular carcinoma. Clinical Liver Disease, 1: 183–185. doi: 10.1002/cld.129
- Issue online: 23 JAN 2013
- Version of Record online: 23 JAN 2013
- 8European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer.EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012;56:908–943.
- 9Treatment of advanced hepatocellular carcinoma by seocalcitol (a vit D analogue): an international randomized double-blind placebo-controlled study in 747 patients. J Hepatol 2003;42:17A., , , , , , et al.